Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer
Clinical trial NCT03822468 · COMPLETED
Trial details
- NCT number
- NCT03822468
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-11
- Primary completion
- 2021-06-11
- Enrollment
- 376
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.